Shenling Keli (肾苓颗粒)肾苓颗粒

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

肾茶是一种在国家药监局注册认定的药品。该药品含有相关活性成分。

该药品关联的活性成分包括:土茯苓Tufu Ling、地黄rehmannia、淡竹叶Danzhu Ye、甘草licorice、肾茶Shen Cha。这些成分信息来自国家药监局数据库。

您可以探索含有相同成分的其他药品:土茯苓-267e25a9成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 肾苓颗粒) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.

Active ingredients associated with this product: 土茯苓Tufu Ling, 地黄rehmannia, 淡竹叶Danzhu Ye, 甘草licorice, 肾茶Shen Cha.

Explore other medicines containing the same ingredient: 土茯苓 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 肾苓颗粒Recorded Chinese name: 肾苓颗粒
  • 剂型Dosage form: 颗粒剂Granules
  • 规格Specification: 每袋装2.5g2.5 g per sachet

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 四川禾正制药有限责任公司Chinese legal name: 四川禾正制药有限责任公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字Z20110033

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字Z20110033

Manufacturer

Chinese legal name: 四川禾正制药有限责任公司 (domestically manufactured)

Traditional functions

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Keep sealed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字Z20110033

生产企业

四川禾正制药有限责任公司(国产)

功能主治

清热解毒.利湿通淋。用于减轻或缓解轻中度急性单纯性下尿路感染下焦湿热证出现的尿频尿急、尿道灼热刺痛、尿黄等症状。

用法用量

开水冲服。一次1袋,一日3次。疗程为7天。

不良反应

少数病例可能出现恶心、上腹不适,腹泻等现象。

禁忌

尚不明确。

注意事项

1.用药3天后症状无明显缓解者,改用或加用其它治疗措施。   
2.合并有上尿路感染、合并复杂性尿路感染、或症状偏重、体温在38.5℃以上者均非本品的适应症。  
3.临床使用期间,应定期进行尿常规、尿细菌学培养等检查,并根据检查结果合理调整治疗方案。   
4.治疗期间出现病情加重者应及时就医检查,并根据检查结果合理调整治疗方案。   
5.治疗期间应注意多休息,多饮水。   
6.个别患者用药后出现BUN明显升高,其原因尚不清楚。   
7.临床试验仅支持7天用药的安全性,不宜超疗程使用。临床使用期间注意肝功能的检查。

贮藏

密封。

规格

每袋装2.5g

证据Evidence

  • 批准文号: 国药准字Z20110033
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.